ereprof. dr. Claus Bachert
- ORCID iD
-
0000-0003-4742-1665
Show
Sort by
-
- Journal Article
- A1
- open access
Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice
-
Effects of biologics treatment in type 2-high chronic rhinosinusitis with nasal polyp patients
(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 151(2, Supplement 1). p.AB187-AB187 -
- Journal Article
- A1
- open access
Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors
-
- Journal Article
- A1
- open access
Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP
-
Online education yields significant gains in physicians' knowledge of eosinophil-associated disorders
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB195-AB195 -
Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma
-
Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial
-
Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB161-AB161 -
Symptom free days in patients with severe chronic rhinosinusitis with nasal polyps treated with dupilumab
-
Advances in chronic rhinosinusitis in 2020 and 2021